SCHEMBL9402194

SCHEMBL9402194

CCCCc1nnc(SCC(=O)OC)n1Cc1ccc(NC(=O)c2ccccc2C(=O)O)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9402214 0.92 — —
SCHEMBL9402339 0.90 — —
SCHEMBL9402264 0.90 — —
SCHEMBL9402209 0.89 — —
SCHEMBL9402369 0.89 — —
SCHEMBL9402395 0.88 — —
SCHEMBL9402275 0.87 — —
SCHEMBL9402274 0.87 — —
SCHEMBL9402273 0.87 — —
SCHEMBL9402334 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3128365-A — — None — — JP disclosed
US-5336778-A Substituted triazoles as angiotensin II antagonists MERCK & CO., INC. (US) 1994-08-09 — — US disclosed
JP-H03128365-A SUBSTITUTED TRIAZOLE AS ANGIOTENSIN II ANTAGONIST MERCK & CO INC 1991-05-31 — — JP disclosed
EP-0409332-A2 Substituted triazoles as angiotensin II antagonists MERCK & CO. INC. (US) 1991-01-23 — — EP disclosed
Send feedback